Posts Tagged: modeling and simulation

Pharma/Biotech spends billions of dollars to determine, as early as possible, which compounds in trials are flawed and can be terminated. Still, about 7 of every 8 drugs introduced into trials fails. Each trial introduction commits the sponsor to spending estimated US$103 million. What if we could predict compound efficacy earlier, prior to the even… Read more »